Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

HOME
Pharma Business
About us
- Media Kit
- Privacy Policy
Contact

Search for:

Tag: Cipla

Cipla launching low-dose Efavirenz 400 mg HIV infection therapy

November 30, 2015 Off

Cipla launching low-dose Efavirenz 400 mg HIV infection therapy

By Dino Mustafić

Cipla launching low-dose Efavirenz 400 mg HIV infection therapy

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies

December 20, 2024 Off

Cosentyx meets the primary endpoints

June 15, 2015 Off

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

Proudly powered by WordPress | Theme: Envo Magazine